Literature DB >> 19804817

Na(+)/Cl(-)/creatine transporter activity and expression in rat brain synaptosomes.

M J Peral1, M D Vázquez-Carretero, A A Ilundain.   

Abstract

Creatine is involved in brain ATP homeostasis and it may also act as neurotransmitter. Creatine transport was measured in synaptosomes obtained from the diencephalon and telencephalon of suckling and 2 month-old rats. Synaptosomes accumulate [(14)C]-creatine and this accumulation was Na(+)- and Cl(-)-dependent and inhibited by high external K(+). The latter suggests that the uptake process is electrogenic. The kinetic study revealed a K(m) for creatine of 8.7 microM. A 100-fold excess of either non-labelled creatine or guanidinopropionic acid abolished NaCl/creatine uptake, whereas GABA uptake was minimally modified, indicating a high substrate specificity of the creatine transporter. The levels of NaCl/creatine transporter (CRT) activity and those of the 4.2 kb CRT transcript (Northern's) were higher in the diencephalon than in the telencephalon, whereas the 2.7 kb transcript levels were similar in both brain regions and lower than those of the 4.2 kb. These observations suggest that the 4.2 kb transcript may code for the functional CRT. CRT activity and mRNA levels were similar in suckling and adult rats. To our knowledge the current results constitute the first description of the presence of a functional CRT in the axon terminal membrane that may serve to recapture the creatine released during the synapsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804817     DOI: 10.1016/j.neuroscience.2009.10.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  New insights into creatine transporter deficiency: the importance of recycling creatine in the brain.

Authors:  Jiddeke M van de Kamp; Cornelis Jakobs; K Michael Gibson; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

Review 2.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

3.  Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Authors:  Hui Li; Ramon F Thali; Christy Smolak; Fan Gong; Rodrigo Alzamora; Theo Wallimann; Roland Scholz; Núria M Pastor-Soler; Dietbert Neumann; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

Review 4.  The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Authors:  Elsa Ghirardini; Francesco Calugi; Giulia Sagona; Federica Di Vetta; Martina Palma; Roberta Battini; Giovanni Cioni; Tommaso Pizzorusso; Laura Baroncelli
Journal:  Genes (Basel)       Date:  2021-07-24       Impact factor: 4.096

5.  Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  J Daniel Sharer; Olaf Bodamer; Nicola Longo; Silvia Tortorelli; Mirjam M C Wamelink; Sarah Young
Journal:  Genet Med       Date:  2017-01-05       Impact factor: 8.822

6.  Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect.

Authors:  Jiddeke M van de Kamp; Petra J W Pouwels; Femke K Aarsen; Leontine W ten Hoopen; Dirk L Knol; Johannes B de Klerk; Ireneus F de Coo; Jan G M Huijmans; Cornelis Jakobs; Marjo S van der Knaap; Gajja S Salomons; Grazia M S Mancini
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

7.  Stuck at the bench: Potential natural neuroprotective compounds for concussion.

Authors:  Anthony L Petraglia; Ethan A Winkler; Julian E Bailes
Journal:  Surg Neurol Int       Date:  2011-10-12

Review 8.  The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.

Authors:  Inge Oudman; Joseph F Clark; Lizzy M Brewster
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.